Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Scientific Reports|June 30, 2022
Comparative effectiveness of low-dose-rate brachytherapy with or without external beam radiotherapy in favorable and unfavorable intermediate-risk prostate cancerHideyasu Tsumura, Nobumichi Tanaka, Tomohiko Oguchi, et al.
World Journal of Radiology|January 12, 2016
Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapyHideyasu Tsumura, Takefumi Satoh, Hiromichi Ishiyama, et al.
Annals of Nuclear Medicine|April 6, 2012
EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapyShinji Kurosaka, Takefumi Satoh, Edward Chow, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trialHideyasu Tsumura, Takefumi Satoh, Hiromichi Ishiyama, et al.
Clinical Genitourinary Cancer|August 23, 2017
Comparison of Sequential Treatment With Androgen Receptor-Targeted Agent Followed by Another Androgen Receptor-Targeted Agent Versus Androgen Receptor-Targeted Agent Followed by Docetaxel in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate CancerNobuaki Matsubara, Yoko Yamada, Ken-Ichi Tabata, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 12, 2008
[Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy]Masaki Kimura, Takefumi Satoh, Miyoko Okazaki, et al.
Cancer Research|November 25, 2003
Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer modelTakefumi Satoh, Takashi Saika, Shin Ebara, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 13, 2019
Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b<sup>+</sup>Gr1<sup>+</sup>MDSCs from bone marrowRyo Takahashi, Hideki Amano, Yoshiya Ito, et al.
The Prostate|September 15, 2017
Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapyHideyasu Tsumura, Hiromichi Ishiyama, Ken-Ichi Tabata, et al.
Journal of Radiation Research|November 14, 2013
High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-upHiromichi Ishiyama, Takefumi Satoh, Masashi Kitano, et al.
Pageof 14